| Biotechnology Industry | Healthcare Sector | Ms. Luo Huang CEO | XSHE Exchange | CNE000001KP1 ISIN |
| CN Country | 1,730 Employees | - Last Dividend | 19 May 2021 Last Split | 23 Jul 2004 IPO Date |
Daan Gene Co., Ltd., a comprehensive entity based in Guangzhou, China, operates primarily in the biotechnological and biomedical fields. Founded in 1988, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It focuses on the research, development, manufacturing, and commercialization of clinical test reagents, instruments, and corresponding consumables. Daan Gene has diversified its operations into two major segments: Biological Products and Related Business, and Financial Business. This diversification reflects not only its core scientific endeavors but also an immersion into financial and consultancy services tailored for the healthcare sector. Among its notable activities are its innovation-driven approaches towards addressing major public health issues, including infectious diseases and cancer, through advanced diagnostics and medical services.
A wide array of reagents and diagnostic instruments for various medical conditions and tests, including hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, and COVID-19. The company emphasizes the crucial role of accurate diagnostics in healthcare through its molecular diagnosis systems, such as polymerase chain reaction (PCR) systems, chemiluminescence immunoassay analyzers, and nucleic acid extraction methods.
During the COVID-19 pandemic, the company leveraged its technological capabilities to offer rapid test kits and viral transport mediums, contributing to global efforts to curb the spread of the virus.
Daan Gene provides innovative solutions for cancer diagnosis and pathology testing, including liquid-based cytology production tools, automatic sample transfer machines, and auto biochemistry analyzers. These products represent the company's commitment to advancing cancer detection and treatment.
Beyond physical products, Daan Gene also offers a suite of health services encompassing genetic susceptibility gene testing, tumor marker testing, and routine physical examinations. These services aim to promote preventive healthcare and personalized medicine, aligning with modern trends in the healthcare industry.
The company's diverse product range is marketed under several brands, including Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech, covering a broad spectrum of medical and pathology tests.
Expanding beyond biotechnological products, Daan Gene engages in an array of services related to hospital investment management, insurance, finance leasing, commercial factoring, and consulting. These services underline the company's intricate involvement in the broader health industry, facilitating access to healthcare advancements.